Pre-APEC US ban on Chinese genomic giant widens biotech decoupling

Beijing has vowed to defend its firms after Washington blocked imports from China’s leading genomics group, extending the two countries’ trade war into biotechnology weeks before their leaders are due to meet in Shenzhen. The US Department of Homeland Security (DHS) on Wednesday added three Shenzhen-based companies …

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.